<output id="05050"><nobr id="05050"></nobr></output>
    <tr id="05050"><nobr id="05050"><delect id="05050"></delect></nobr></tr>

      1. Home
        About
        Products
        Specialties
        Gastrointestinal Surgery
        Urology
        Thoracic Surgery
        Gynecology
        Hepatic-biliary-pancreatic Surgery
        Thyroid & Breast Surgery
        Support
        User Manual
        REACH
        DEMO
        Contact
        CN
        About Us

        Shanghai SAINTS SAGES Surgical Co., Ltd. is committed to be a leader in the field of minimally invasive devices.


        With head office in Shanghai Zhangjiang Science City, Saints Sages has overall layout of the upstream and downstream of the industrial chain in Shanghai, Jiangsu and Hunan. We’re mainly engaged in R&D, production and sales of minimally invasive surgical medical devices.


        Established in 2017, Saints Sages has successfully developed several energy device products which are widely used in minimally invasive surgery, hepatobiliary surgery, gynecology, urology, thoracic surgery and other departments. We have full core intellectual property rights in related product fields, and some products are the first in the world.


        As a minimally invasive surgical innovation medical device company based in China and has vision for global markets, Saints Sages will continue to closely follow the clinical needs and develop more innovative minimally invasive surgical devices to serve global patients by relying on the professional R&D team and years of clinical transformation experiences.

        History
        2017.12
        2018.08
        2019.08
        2020.07
        2020.09
        2020.11
        2020.11
        2021.11

        Company establishment

        The Company received multimillion USD of angel round investment led by Vocanics Capital with Highlight Capital following.

        The Company received multimillion USD of Pre-A round investment led by Northern Light Venture Capital with Lapam Capital following.


        SanAgile I completed clinical trial enrollments at Shanghai Ruijin Hospital and Shanghai Changzheng Hospital.

        SanAgile I completed animal experiments.

        The Company received 15M USD of round A investment led by Qiming Venture Partners with TF Capital following.

        SanPulse I completed development.

        Culture
        • We seamlessly integrate clinical needs and assist medics to improve patients’ postoperative recovery as well as their wellbeing

        • We conduct independent R&D as well as innovation and commit to take innovation as the first driving force.

        • Implementing the life cycle of medical products, we always take "win-win" as the principle to ensure the healthy development of resource-based ecological chain.

        • We take the development of the industry as our own responsibility and use our knowledge to promote the healthy and sustainable development of China's medical industry.

        久久网直播欧洲亚洲,欧美久久久久久久综合网,欧美精品久久九九精品观看,久久精品亚洲AV无码四区妖精